Back to Journals » Therapeutics and Clinical Risk Management » Volume 10

Emerging treatments in type 2 diabetes: focus on canagliflozin

Total article views   Abstract views HTML views PDF downloads Totals
8,568 Dovepress* 5,303 1,314+ 1,950 6,617
PubMed Central* 0 1,951 903 1,951
Totals 5,303 3,265 2,853 8,568
*Since 21 August 2014
+Since July 2016

View citations on PubMed Central and Google Scholar